-The Indian Express The government will be analysing mortality figures during drug trials in India following WHO data showing that 2,031 people died between 2008 and 2011 in such trials in the country. That amounts to about 10 people per week, or more than one person a day. At the same time, the data shows that only 1.5 per cent of clinical trials held across the world so far (2,770 of 1,76,641)...
More »SEARCH RESULT
Waiting for a law-Dr KM Shyamprasad
Regulations covering public health should override personal rights and the country cannot wait any more for a good public health law. The health care industry, including institutions of medical education, hospitals and pharmaceutical businesses, have grown into behemoths that can do considerable harm in the absence of independent and effective regulatory systems. While there are no success stories in the regulation of any kind of industry in India, I will focus...
More »Been there, done that-Santosh Singh
-The Indian Express Only the names of the patients have changed. Acute encephalitis syndrome is back in Bihar, hitting the same districts as every year, its victims once again mostly children of Mahadalit communities living in various degrees of poverty, their resistance levels lowered by malnutrition and exposure to heat. And the government response has been repetitive to the point of being ritualistic. It has asked for Central assistance and set up...
More »No antibiotics to be allowed in honey-Savvy Soumya Misra
-Down to Earth Food safety authority approves scientific panel's recommendations for regulating honey quality India has inched closer to regulating antibiotics in honey with the apex food safety body of the country approving the recommendations of its own scientific panel and committee on fixing rules for antibiotics in honey. The recommendations put forth by the scientific panel, which says antibiotics should not be used at any stage of honey production, has been...
More »Doc panel for drug approval
-The Telegraph The Centre today asked a panel of doctors to outline measures to improve drug approval procedures, three days after a parliamentary standing committee said India’s drug regulators had broken laws, ignoring the interests of patients. The panel announced by the Union health ministry has been asked to suggest steps to improve the procedural aspects of the Central Drugs Standards Control Organisation (CDSCO), the agency entrusted with approving medicines for sale...
More »